Abstract Submission has been closed.
Thank you for your contribution.
Late Breaking Abstract
If you want to submit a late breaking abstract please contact the ISDS Scientific Secretariat via email@example.com.
Meeting attendees who have submitted a scientific abstract are eligible for travel grants. We would particularly invite students, post docs and early career scientists to apply. If you want to apply for a travel grant please send your CV to firstname.lastname@example.org.
You are required to indicate whether you have received a significant financial interest, consultancy or other relationship with products, manufacturer(s) of products or providers of services or financial support related to this abstract. If yes, the conflict of interest/relationship needs to be reported in the abstract submission process.
The completion of the following affirmations is mandatory in order to submit your abstract:
- Content of abstract
I hereby confirm that my abstract is based on previously unpublished data and that I own the rights to the written summaries of research or observations presented in the abstract, or that I have obtained permission for the acknowledged sources for other excerpts taken from copyrighted works.
In submitting an abstract I hereby agree that the copyright of my abstract is transferred to the Inflammatory Skin Disease Summit 2018.
- I hereby confirm that I will present my abstract at the congress in case it is accepted
Abstracts may be submitted in English only. Authors will be able to draft the abstracts online and may return to the site to edit the texts of the abstracts if necessary. Authors are free to finalise their texts and submit their abstracts at any time before Thursday, September 20, 2018, 11:59pm CET+1.
During the submission process, authors may indicate their preferred presentation type (Oral presentation or poster presentation). The final decision in regards to the presentation type, however, will be taken by the Scientific Committee. Submission of an abstract constitutes a commitment by the author to present at the congress if accepted.
No changes can be made after this deadline.
Notification of acceptance and information regarding presentations will be forwarded to the authors immediately after the reviewing process by e-mail the latest by Monday, October 1, 2018. If an abstract is accepted it is mandatory for the presenting author to attend the congress.
Modalities of free paper and poster presentations will be sent with the notification of acceptance. Accepted posters will be accessible to delegates in the poster exhibition area.
For an abstract to be included in the final scientific programme, it is mandatory for the presenting author to register for the congress and to settle payment as soon as the notification of abstract acceptance is received (Monday, October 1, 2018) and not later than Wednesday, October 10, 2018.
By submitting an abstract, copyrights are transmitted automatically to the Inflammatory Skin Disease Summit. Abstracts will be published in a supplement of the Experimental Dermatology as they have been received.
For questions please contact the ISDS Scientific Secretariat:
Mondial Congress & Events
1040 Vienna, Austria
P +43 1 58804-0
F + 43 1 58804-185